Recent studies have also demonstrated that adding specific signal peptides to mRNA sequences encoding tumor antigens can promote presentation via MHC class II molecules, thereby stimulating CD4+ T helper cell responses [122]. This evidence concerns the gene CD4 and neoplasm.